Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

CVD 103-HgR is a live oral cholera vaccine strain constructed by deleting 94% of the gene for the enzymatically active A subunit of cholera toxin from classical Inaba Vibrio cholerae O1 569B; the strain also contains a mercury resistance gene as an identifying marker. This vaccine was well tolerated...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tacket, Carol O., Cohen, Mitchell B., Wasserman, Steven S., Losonsky, Genevieve, Livio, Sofie, Kotloff, Karen, Edelman, Robert, Kaper, James B., Cryz, Stanley J., Giannella, Ralph A., Schiff, Gilbert, Levine, Myron M.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1999
Teme:
Microbial Immunity and Vaccines
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC97039/
https://ncbi.nlm.nih.gov/pubmed/10569747
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki